Literature DB >> 3409209

Isolation and identification of a tumour reducing component from mistletoe extract (Iscador).

G Kuttan1, D M Vasudevan, R Kuttan.   

Abstract

Using a combination of gel filtration and paper chromatography, a tumour reducing component from mistletoe extract (Iscador) was isolated and identified to be a peptide of approximate molecular weight 5000. The isolated peptide reduced the solid tumour induced by Dalton's lymphoma ascites tumour cells (DLA cells) in mice. The isolated component was very cytotoxic to the DLA cells but was not cytotoxic to normal lymphocytes, indicating a cell dependent specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409209     DOI: 10.1016/0304-3835(88)90292-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

Review 1.  Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-05       Impact factor: 8.262

2.  Anticancer Activity of Garcinia morella on T-Cell Murine Lymphoma Via Apoptotic Induction.

Authors:  Bhaswati Choudhury; Raghuram Kandimalla; Rupjyoti Bharali; Javadi Monisha; Ajaikumar B Kunnumakara; Kasturi Kalita; Jibon Kotoky
Journal:  Front Pharmacol       Date:  2016-01-29       Impact factor: 5.810

3.  A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients.

Authors:  Alessandra Longhi; Marcus Reif; Erminia Mariani; Stefano Ferrari
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-31       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.